The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.50
Bid: 71.00
Ask: 72.00
Change: 0.50 (0.70%)
Spread: 1.00 (1.408%)
Open: 71.50
High: 72.00
Low: 71.50
Prev. Close: 71.00
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading & Company Update

19 Jan 2021 07:00

RNS Number : 0978M
TruFin PLC
19 January 2021
 

 

19 January 2021

 

TruFin plc("TruFin" or the "Company" or together with its subsidiaries the "Group")

 

Trading & Company Update

 

TruFin is pleased to announce that revenues for the 12 months ended 31 December 2020 are expected to be significantly ahead of market expectations at approximately £14.6m (FY19: £7.3m), representing year-on-year growth in excess of 100%. This has predominantly been driven by strong performance from the console division of Playstack Ltd ("Playstack") which, despite the further national lockdowns, has been supported by robust performance across the rest of the Group.

 

As a result, the Adjusted Loss Before Tax ('LBT') is also expected to be ahead of market expectations at no more than £8.4m (FY19: LBT of £9.3m).

 

Oxygen

 

Oxygen Finance Group Limited (together with its subsidiaries, Oxygen Finance Limited, Oxygen Finance Americas, Inc. and Porge Limited) ("Oxygen") continued to make considerable progress. The client portfolio has been strengthened with five new Early Payment ("EP") clients, three multi-year renewals by existing clients and four existing clients went live, all achieved despite the economic restrictions.

 

The second half of 2020 saw strong growth in suppliers signing up to Oxygen's Early Payment programmes. This, combined with cost control measures, resulted in EBITDA profitability in Q2, Q3 and Q4 of 2020. This positive momentum highlights Oxygen's dominance in its niche market.

 

Satago

 

Satago Financial Solutions Limited's ("Satago") has continued to develop its core technology and lending as a service ("LaaS") solution and remains well positioned notwithstanding reduced lending activity due to the Covid-19 pandemic. In December 2020, TruFin announced that Satago had entered into a six-month commercial pilot with a Tier-1 Bank which, if successful, is expected to lead to a five-year commercial agreement.

 

Playstack

 

During the year Playstack secured two significant contracts with major technology platforms, and successfully launched the console game 'Mortal Shell', which has made a material contribution to the Group's full year revenue. During 2021, Playstack will continue to develop its own innovative technology that increases the revenue generating potential of its game portfolio, whilst extending the reach of its financing services through partnerships with third-party lenders.

 

Vertus

 

The loan book of Vertus Capital Limited ("Vertus") continues to perform exceptionally well, with no credit losses incurred to date and a growing pipeline. Vertus is on track to reach its loan book target of £16m during Q1 2021 and as a result turn profitable on a monthly basis during 2021.

 

Company Update

 

Further to the Company's interim results statement on 25 September 2020 and given the strong performances within the Group, TruFin has formally engaged advisers to explore options for Oxygen and Vertus. This may result in the sale of Oxygen and / or Vertus and further return of capital to shareholders, should the board believe it to be in the best interests of shareholders. However, there is no certainty that such sales will occur.

 

James van den Bergh, Chief Executive Officer, commented: "Given the continued momentum within all the subsidiaries, the Board looks to the future with confidence. Each of the subsidiaries is considerably de-risked compared to twelve months ago and the Group is fully funded to achieve profitability. Oxygen and Vertus continue to dominate their niches and both have delivered new client wins in the face of the pandemic. Satago's recently announced commercial pilot with a Tier-1 Bank exemplifies the partnership model that TruFin continues to promote within the Group and we are all pleased with the success that Playstack has achieved."

 

 

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward ThomasLouis Davies

 

0203 100 2000

 

 

 

TruFin plc is the holding company for an operating group of companies that are niche lenders and early payment providers. TruFin Group combines the benefits of both the traditional relationship banking model and developments in the fintech sector. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website www.TruFin.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFVLLFFFLEBBB
Date   Source Headline
2nd May 20245:49 pmRNSNotice of AGM
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.